Edition:
United Kingdom

Molecular Medicine SpA (MLMD.MI)

MLMD.MI on Milan Stock Exchange

0.52EUR
23 Feb 2018
Change (% chg)

€-0.00 (-0.38%)
Prev Close
€0.53
Open
€0.53
Day's High
€0.53
Day's Low
€0.52
Volume
2,122,598
Avg. Vol
6,533,041
52-wk High
€0.60
52-wk Low
€0.40

Chart for

About

Molecular Medicine SpA (MolMed) is an Italy-based company engaged in the medical biotechnology sector. The Company is active in the research, development and clinical validation of therapies for the treatment of cancer. The Company’s activities include identification and development of bio-pharmaceuticals reducing the tumor mass... (more)
No analyst recommendations are available for .

Overall

Beta: 0.99
Market Cap(Mil.): €184.88
Shares Outstanding(Mil.): 444.96
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Molmed: Dompé Exercises Option To Start Zalmoxis In Switzerland, Turkey And Australia

* DOMPÉ EXERCISES OPTION TO ENTER MARKETS IN SWITZERLAND, TURKEY AND AUSTRALIA TO SELL ZALMOXIS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

08 Feb 2018

BRIEF-Molmed: Italian Medicines Agency Sets Price Of Reimbursement For Zalmoxis

* ITALIAN MEDICINES AGENCY SETS GROSS PRICE OF REIMBURSEMENT FOR ZALMOXIS AT EUR 149,000 PER INFUSION Source text for Eikon: Further company coverage: (Gdynia Newsroom)

13 Dec 2017

BRIEF-Molmed submits utilization request for third tranche of share capital increase

* SUBMITTED UTILIZATION REQUEST FOR THIRD TRANCHE OF SHARE CAPITAL INCREASE TO BE RESERVED TO SOCIETE GENERALE AS PER SEF AGREEMENT

21 Sep 2017

Earnings vs. Estimates